The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60.

The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...

Ritchey cited early signs of respiratory syncytial virus, or RSV, starting to increase this season as expected in Florida, which is called out at the top of this week's report. Behind the CDC's ...

When you buy through links on our articles, Future and its syndication partners may earn a commission. Adults ages 75 and older should get a single dose of an RSV vaccine, the CDC says. Younger ...

Studies presented to the CDC ACIP Work Group for RSV found both vaccines from fall 2023 may result in a slightly elevated risk of Guillain-Barré syndrome, a rare but serious condition.

In adults 60 and over, vaccine effectiveness from October 2023 to March 2024 against RSV-associated hospitalization reached 75% (95% CI 50-87), according to researchers led by Diya Surie, MD, of ...

The CDC says that, yearly, RSV leads to 58,000–80,000 hospitalizations among children younger than 5 years old and 100,000–150,000 hospitalizations among adults 60 years and older.